Skip to content

Clinical study of octreotide assisted endoscopic ultrasonography in gastrointestinal tract

Clinical study of octreotide assisted endoscopic ultrasonography in gastrointestinal tract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015090
Enrollment
Unknown
Registered
2018-03-07
Start date
2018-05-31
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal tumor of gastrointestinal tract

Interventions

A:Subcutaneous injection of octreotide 0.1mg was performed 15 minutes before endoscopic ultrasonography
B:Subcutaneous saline 0.1mg injection was taken 15 minutes before endoscopic ultrasonography

Sponsors

Endoscopy Center of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients with gastrointestinal submucosal tumors (SMT) are required to undergo endoscopic ultrasonography, 18 to 85 years old; 2. The patients can be associated with gastrointestinal symptoms (abdominal pain, diarrhea, fecal occult blood positive, unexplained hematochezia, bowel habits and traits change and so on); 3. The subjects themselves or their guardians have signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Poor bowel preparation; (2) Definite contraindication for endoscopy; (3) Serious heart and lung disease; (4) Acute gastrointestinal bleeding (not including bleeding hemorrhoids); (5) History of colon resection; (6) Severe mental illness who can not be self rating or not accept enrollees; (7) Cconfirmed or suspected intestinal obstruction; (8) Painless enteroscopy; (9) Refused to sign the consent.

Design outcomes

Primary

MeasureTime frame
Total lesion detection rate;

Secondary

MeasureTime frame
Clear image acquisition time;Evaluation of operation difficulty;Adverse reaction;

Countries

China

Contacts

Public ContactWang Jinhai

Division of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University,

jinhaiwang@hotmail.com+86 13609281113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026